Short Interest: Could EASTON PHARMACEUTICA (OTCMKTS:EAPH) Go Up After Its Newest Short Interest Report?

December 1, 2016 - By Marguerite Chambers   ·   0 Comments

Short Interest: Could EASTON PHARMACEUTICA (OTCMKTS:EAPH) Go Up After Its Newest Short Interest Report?

The stock of EASTON PHARMACEUTICA (OTCMKTS:EAPH) registered an increase of 80.84% in short interest. EAPH’s total short interest was 151,000 shares in December as published by FINRA. Its up 80.84% from 83,500 shares, reported previously. About 2.72 million shares traded hands. Easton Pharmaceuticals Inc (OTCMKTS:EAPH) has risen 218.92% since May 4, 2016 and is uptrending. It has outperformed by 212.99% the S&P500.

Easton Pharmaceuticals, Inc. is a development-stage firm engaged in various pharmaceutical sectors and others industries. The company has a market cap of $9.68 million. The Firm has a transdermal delivery technology , which is incorporated in a line of therapeutic over-the-counter (OTC) products. It currently has negative earnings. The Firm owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions.

EAPH Company Profile

Easton Pharmaceuticals, Inc., incorporated on July 24, 1998, is a development-stage firm engaged in various pharmaceutical sectors and others industries. The Firm has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Firm owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions. The Company’s products are in various stages of commercialization.

More news for Easton Pharmaceuticals Inc (OTCMKTS:EAPH) were recently published by: Marketwatch.com, which released: “Easton Pharmaceuticals Announces Negotiations For The Filing Of A Medical …” on November 28, 2016. Marketwatch.com‘s article titled: “Easton Pharmaceuticals Announces It Has Moved Toward Signing Sales …” and published on May 10, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marguerite Chambers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>